Extent of beta cell destruction is important but insufficient to predict the onset of type 1 diabetes mellitus.
BACKGROUND
Type 1 diabetes mellitus is characterized by an inability to produce insulin endogenously. Based on a series of histopathology studies of patients with recent onset of the disease, it is commonly stated that the onset of clinical symptoms corresponds to an 80-95% reduction in beta cell mass. Motivated by the clinical importance of the degree of beta cell destruction at onset, a meta-analysis was used to determine the validity of this common wisdom.


RESULTS
The histopathology results identifying insulin containing islets in patients younger than 20 years of age were extracted from three different studies. The results for 105 patients were stratified by duration of diabetic symptoms and age at onset. Linear regression and a non-parametric bootstrap approach were used to determine the dependence of residual beta cell mass to age at onset. The percentage reduction in beta cell mass was highly correlated (p<0.001) with the age of onset with the greatest reduction in beta cell mass in the youngest patients. As this trend had not been previously observed, an alternative physiology-based model is proposed that captures this age-dependence.


CONCLUSIONS
The severity in beta cell reduction at onset decreased with age where, on average, a 40% reduction in beta cell mass was sufficient to precipitate clinical symptoms at 20 years of age. The observed trend was consistent with a physiology-based model where the threshold for onset is based upon a dynamic balance between insulin-production capacity, which is proportional to beta cell mass, and insulin demand, which is proportional to body weight.
Klinke
David J
DJ
Department of Chemical Engineering, West Virginia University, Morgantown, West Virginia, USA. david.klinke@mail.wvu.edu
D017668:Age of Onset; D003922:Diabetes Mellitus, Type 1 / Q000473:pathology*; D006801:Humans; D007515:Islets of Langerhans / Q000473:pathology*; D008962:Models, Theoretical